Delivery Order SPE2DB22D2214-SPE2DB25FS6TE
Award Date 9/29/25
Potential Completion Date 10/21/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LUMAKRAS 320 mg tablets (90-count) with a ceiling value of $13,491.97. This firm fixed-price contract, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a $13,491.97 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of LUMAKRAS 320 mg tablets (90-unit quantity). This competitive award, utilizing firm fixed pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract involves no set-aside designation, with performance to be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for LUMAKRAS 320 mg tablets (90-count supply) on September 25, 2025, with a ceiling value of $13,491.97 and ultimate completion date of October 17, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $13,491.97 to AmerisourceBergen Drug Corp for 90 tablets of LUMAKRAS 320 mg, a prescription medication used in cancer treatment. This competitive award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, represents a firm fixed-price delivery order with no set-aside designation. The pharmaceutical will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- This is a $13,491.97 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of June 20, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a significant vendor for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX to provide a wide...
- This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ03N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,121.56 Firm Fixed Price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $13,304 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562327556 LUMAKRAS 320 MG tablets. As the prime contractor, Amerisourcebergen will deliver 90 tablets to a facility in Conshohocken, Pennsylvania, under a contract running from September 27 to October 19, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency functions to provide logistics support to the Department of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lazicluze 240 mg tablets (30-count units) with a ceiling value of $12,446.16. This firm fixed-price delivery order, with an ultimate completion date of July 9, 2025, represents a non-competitive set-aside transaction executed against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, for the supply of Lazcluze 240 mg tablets in quantities of 30 units. This firm fixed price delivery order carries a ceiling value of $12,446.16 and is scheduled for completion by August 4, 2025. The award was made through open competition with no set-aside designation, and the pharmaceutical products will be delivered to the contractor's location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lorbrena 100 mg tablets in quantities of 30. This firm fixed-price delivery order, valued at $11,624.35, represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...